14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.30 $2.95 Tuesday, 23rd Apr 2024 CLLS stock ended at $2.62. This is 0.769% less than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 7.71% from a day low at $2.46 to a day high of $2.65.
90 days $2.30 $3.13
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Mar 24, 2021 $20.33 $20.33 $18.31 $18.50 479 520
Mar 23, 2021 $21.24 $21.32 $20.03 $20.31 193 986
Mar 22, 2021 $21.38 $22.20 $21.00 $21.67 219 109
Mar 19, 2021 $20.02 $21.43 $20.02 $21.43 378 052
Mar 18, 2021 $20.71 $21.12 $19.75 $19.81 205 922
Mar 17, 2021 $21.12 $21.78 $20.67 $21.23 210 384
Mar 16, 2021 $22.90 $24.02 $21.83 $21.96 470 397
Mar 15, 2021 $20.26 $22.33 $20.10 $21.76 482 998
Mar 12, 2021 $20.66 $20.66 $19.70 $19.95 279 012
Mar 11, 2021 $20.33 $21.83 $20.26 $21.32 307 258
Mar 10, 2021 $22.08 $22.25 $20.11 $20.13 444 867
Mar 09, 2021 $18.97 $21.81 $18.83 $21.65 1 074 356
Mar 08, 2021 $19.01 $19.60 $18.19 $18.28 560 125
Mar 05, 2021 $19.29 $19.29 $17.00 $18.19 775 323
Mar 04, 2021 $20.19 $20.40 $18.50 $19.31 621 068
Mar 03, 2021 $21.84 $22.08 $19.85 $20.14 415 526
Mar 02, 2021 $22.53 $22.76 $22.02 $22.16 224 644
Mar 01, 2021 $21.81 $23.17 $21.81 $22.69 226 627
Feb 26, 2021 $21.62 $22.12 $20.12 $21.50 383 265
Feb 25, 2021 $21.99 $22.60 $20.19 $20.64 346 077
Feb 24, 2021 $22.26 $23.17 $21.71 $22.47 279 733
Feb 23, 2021 $22.85 $22.85 $18.80 $21.94 704 937
Feb 22, 2021 $24.08 $24.46 $22.95 $23.26 354 362
Feb 19, 2021 $24.26 $25.59 $24.19 $25.09 246 139
Feb 18, 2021 $24.80 $25.14 $23.51 $24.02 543 831
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT